LEXATUMUMAB

UNII:	967Q0SJD77
Formula:
Preferred Substance Name:	LEXATUMUMAB

845816-02-6
ETR2-ST01
HGS1018
HGS-1018
HGS-ETR2
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
LEXATUMUMAB [INN]
LEXATUMUMAB [USAN]
LEXATUMUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEXATUMUMAB

Synonyms and Mappings

Resources